A new drug, FLAV-27, targets epigenetic changes in Alzheimer’s. In preclinical studies, the drug reduced levels of ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease.

Researchers developed FLAV-27, an epigenetic drug that inhibits G9a to restore gene expression in Alzheimer’s models. The treatment reduced amyloid and tau, improved cognition and synaptic function, ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering ...

GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

More than 7 million Americans currently have Alzheimer’s disease (AD). That’s according to the Alzheimer’s Association. One out of every nine seniors over age 65 will experience some degree of ...

Over seven million Americans currently have Alzheimer disease (AD). That’s according to the Alzheimer’s Association. One out of every nine seniors over 65 will experience some degree of dementia.

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease. Unlike ...

Add Yahoo as a preferred source to see more of our stories on Google. Drugs that halt Alzheimer’s should be rolled out more widely, Baroness Casey has said. In her first speech since she was appointed ...

Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team found that removing an enzyme from neurons in the brain substantially reduces ...

Esther Landhuis is a journalist in the San Francisco Bay Area. She holds a Ph.D. in immunology and covers biomedicine in all dimensions, from bench discoveries to biotech to health care. Alzheimer’s ...

In an exciting breakthrough, researchers have identified cancer drugs that might reverse the effects of Alzheimer's disease in the brain. By analyzing gene expression in brain cells, they discovered ...